CL2017001433A1 - Compuestos a base de cumarina y métodos asociados - Google Patents

Compuestos a base de cumarina y métodos asociados

Info

Publication number
CL2017001433A1
CL2017001433A1 CL2017001433A CL2017001433A CL2017001433A1 CL 2017001433 A1 CL2017001433 A1 CL 2017001433A1 CL 2017001433 A CL2017001433 A CL 2017001433A CL 2017001433 A CL2017001433 A CL 2017001433A CL 2017001433 A1 CL2017001433 A1 CL 2017001433A1
Authority
CL
Chile
Prior art keywords
based compounds
coumarin
associated methods
cumarine
synthesis
Prior art date
Application number
CL2017001433A
Other languages
English (en)
Inventor
Anthony De Jesus Sanchez
Original Assignee
Biosearch Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosearch Tech Inc filed Critical Biosearch Tech Inc
Publication of CL2017001433A1 publication Critical patent/CL2017001433A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/12—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 3 and unsubstituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/16—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)

Abstract

<p>LA PRESENTE INVENCIÓN SE REFIERE GENERALMENTE A COMPUESTOS A BASE DE CUMARINA QUE PUEDEN USARSE PARA EL ETIQUETADO DE MOLÉCULAS BIOLÓGICAS, ASÍ COMO MÉTODOS DE SÍNTESIS Y DE ENSAYO RELACIONADOS. LOS COMPUESTOS A BASE DE CUMARINA NORMALMENTE SOBREVIVEN A LAS CONDICIONES NECESARIAS PARA LA SÍNTESIS AUTOMATIZADA DE ÁCIDOS NUCLÉICOS SIN EXPERIMENTAR NINGÚN GRADO SUSTANCIAL DE DEGRADACIÓN O ALTERACIÓN.</p>
CL2017001433A 2015-01-20 2017-06-06 Compuestos a base de cumarina y métodos asociados CL2017001433A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562125431P 2015-01-20 2015-01-20

Publications (1)

Publication Number Publication Date
CL2017001433A1 true CL2017001433A1 (es) 2017-12-15

Family

ID=56417579

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017001433A CL2017001433A1 (es) 2015-01-20 2017-06-06 Compuestos a base de cumarina y métodos asociados

Country Status (15)

Country Link
US (1) US11034677B2 (es)
EP (1) EP3247710B1 (es)
JP (2) JP6814139B2 (es)
CN (1) CN107207480B (es)
AU (1) AU2016209680B2 (es)
BR (1) BR112017013027A2 (es)
CA (1) CA2970353C (es)
CL (1) CL2017001433A1 (es)
DK (1) DK3247710T5 (es)
ES (1) ES2931081T3 (es)
MY (1) MY186450A (es)
PL (1) PL3247710T3 (es)
SG (1) SG11201705411SA (es)
WO (1) WO2016118305A1 (es)
ZA (1) ZA201704200B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108148574B (zh) * 2018-02-06 2020-06-16 中国刑事警察学院 可视化检验射击残留物的荧光探针及其制备方法和用途
EP4453246A4 (en) 2021-12-20 2025-12-24 Countable Labs Inc DIGITAL DETECTION AND QUANTIFICATION OF MULTIPLE TARGETS

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1088261A (zh) 1992-07-17 1994-06-22 阿普罗精内斯有限公司 使用3sr扩增法原位检测核酸
WO1994002644A1 (en) 1992-07-17 1994-02-03 Aprogenex, Inc. In situ detection of nucleic acids using 3sr amplification
US6495676B1 (en) 1993-04-13 2002-12-17 Naxcor Nucleic acid sequence detection employing probes comprising non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents
AU719277B2 (en) 1995-03-09 2000-05-04 Naxcor Non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents
US6727356B1 (en) 1999-12-08 2004-04-27 Epoch Pharmaceuticals, Inc. Fluorescent quenching detection reagents and methods
DE10329860A1 (de) 2003-07-02 2005-01-20 Atto-Tec Gmbh Sulfonamidderivate polycyclischer Farbstoffe für analytische Anwendungen
US7705150B2 (en) * 2004-02-04 2010-04-27 Biosearch Technologies, Inc. Cyanine dyes
US7759470B2 (en) 2006-02-20 2010-07-20 Roche Diagnostics Operations, Inc. Labeling reagent
US20090156421A1 (en) * 2007-11-06 2009-06-18 Wyeth Assays and methods for evaluating multimeric complexes
US20090197254A1 (en) 2007-12-14 2009-08-06 Ming-Chou Lee Variant scorpion primers for nucleic acid amplification and detection
US20100029017A1 (en) * 2008-07-29 2010-02-04 Becton, Dickinson And Company Mono-chlorinated hydroxycoumarin conjugates
US20120016128A1 (en) * 2010-07-16 2012-01-19 Zhenjun Diwu Rhodamine lactone phosphoramidites and polymers
FR3026698B1 (fr) * 2014-10-01 2018-05-04 U-Shin France Antivol pour colonne de direction de vehicule automobile

Also Published As

Publication number Publication date
EP3247710B1 (en) 2022-10-19
DK3247710T3 (en) 2022-11-14
SG11201705411SA (en) 2017-08-30
JP2021020903A (ja) 2021-02-18
CA2970353A1 (en) 2016-07-28
NZ732153A (en) 2024-07-05
CA2970353C (en) 2021-07-06
US20170015652A1 (en) 2017-01-19
CN107207480A (zh) 2017-09-26
BR112017013027A2 (pt) 2018-01-09
EP3247710A4 (en) 2018-10-10
US11034677B2 (en) 2021-06-15
DK3247710T5 (da) 2024-09-16
CN107207480B (zh) 2021-06-25
WO2016118305A1 (en) 2016-07-28
AU2016209680A1 (en) 2017-06-08
AU2016209680B2 (en) 2020-09-03
JP2018505141A (ja) 2018-02-22
ES2931081T3 (es) 2022-12-23
ZA201704200B (en) 2021-10-27
JP6814139B2 (ja) 2021-01-13
EP3247710A1 (en) 2017-11-29
MY186450A (en) 2021-07-22
PL3247710T3 (pl) 2023-03-06

Similar Documents

Publication Publication Date Title
BR112018006471A2 (pt) compostos úteis como moduladores de trpm8
DOP2017000298A (es) Reguladores de nrf2
MX388460B (es) Composiciones de yodo.
CO2018000648A2 (es) Compuestos de piridina sustituidos, intermediarios para su preparación y composiciones que los comprenden
MX2019003735A (es) Formulaciones diluibles de cannabinoides y procesos para su preparacion.
UY37134A (es) Compuestos heteroarilos y composiciones que los contienen útiles como inhibidores de pad4
CL2017001046A1 (es) Inhibidoes del bromodominio
CL2018001361A1 (es) Inhibidores éster de acc y usos de los mismos
ECSP16061758A (es) Moduladores de tetrahidropiridopirazinas de gpr6
CR20160272A (es) REGULADORES DE Nrf2
MX2018000511A (es) Derivados de fenoximetilo.
UY36705A (es) Compuestos de 4-hidroxi-3-(heteroaril)piridin-2-ona como agonistas de apj
UY35814A (es) ?lugares óptimos para la soja?.
MX2018009938A (es) Profarmacos de hormona paratiroidea (pth).
ECSP17023281A (es) Inhibidores de mk2 y sus usos
CL2019000033A1 (es) Variantes de xilanasa y polinucleótidos que las codifican.
ECSP17031525A (es) Composiciones novedosas, usos y métodos para hacerlas
MX2016010675A (es) Compuestos condensados de [1,4]diazepina como inhibidores de produccion de la autotaxina (atx) y acido lisofosfatidico (lpa).
BR112015023026A2 (pt) indicador de esterilização para esterilizantes oxidativos e processo para determinar a eficácia de um processo de esterilização utilizando esterilizantes oxidativos
UY34897A (es) Profarmacos de inhibidores peptidicos de expoxi cetona proteasa
MX2017007377A (es) Compuestos organicos.
CL2017002170A1 (es) Desacetoxitubulisina h y análogos de esta.
MX2017001352A (es) Derivados de pirrolidinona como inhibidores de metionina aminopeptidasa 2 (metap-2).
MX2018007390A (es) Composiciones que comprenden acido 15-hidroxi eicosapentaenoico (15-hepe) y metodos de uso del mismo.
CR20160448A (es) Nuevos derivados de piridina